New Delhi [India], April 14 (ANI): Following Congress leader Rahul Gandhi's remarks on Sunday that the government must protect corporate entities from "foreign interests", the Congress party has demanded the Centre to be careful and instruct SEBI and RBI to take appropriate steps to thwart any takeover attempts being made for pharmaceutical and insurance companies in the country till normalcy returns and economic activity is revived.
"We are concerned about the takeover attempts of many Indian pharmaceutical entities which are making critical medicines that are required by the country, and also the verticals as I have mentioned - injectables, antibiotics. There has to be a policy and India must not allow takeovers until normalcy returns and economic activity is revived. This should also apply to the insurance companies," Deputy Leader of Opposition in the Rajya Sabha, Anand Sharma, said.
Congress has also put forward a suggestion to the Central government saying it should not worry about fiscal deficit and current account deficit as this is an "extraordinary" economic situation.
Sharma said the government should give more in relief as less than 1 per cent of the GDP has been given to the COVID relief fund, whereas, many countries have given as much as 15 per cent, for example, USA and Spain. He also said that during the 2008 economic crisis, the then UPA government had given 3 per cent of the GDP as a stimulus.
"The government should not care for CAD (current account deficit) and inflation as this is an extraordinary situation and it should give second financial assistance to these sectors," Sharma said.
Commenting upon the condition of economic slowdown, former Congress President Rahul Gandhi had earlier tweeted saying, "The massive economic slowdown has weakened many Indian corporates making them attractive targets for takeovers. The government must not allow foreign interests to take control of any Indian corporate at this time of national crisis.
Disclaimer: No Business Standard Journalist was involved in creation of this content
You’ve reached your limit of {{free_limit}} free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →
Smart Quarterly
₹900
3 Months
₹300/Month
Smart Essential
₹2,700
1 Year
₹225/Month
Super Saver
₹3,900
2 Years
₹162/Month
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors


Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share


Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor


Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements


Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app
